Targeted Delivery of Immunotoxin by Antibody to Ganglioside GD3: A Novel Drug Delivery Route for Tumor Cells

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Torres Demichelis, Vanina ^a   Vilcaes, Aldo A ^a   Iglesias Bartolomé, Ramiro ^a,b   Ruggiero, Fernando M ^a   Daniotti, Jose L ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GD3; IMMUNOTOXIN; MONOCLONAL ANTIBODY R24; SAPORIN;

ANIMAL CELL; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL CULTURE; CELL SURFACE; CLONOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; EPITHELIUM CELL; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTERNALIZATION; MELANOMA CELL; MOUSE; NONHUMAN; TUMOR CELL;

ANIMALS; ANTIBODIES; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; DRUG DELIVERY SYSTEMS; ENDOSOMES; GANGLIOSIDES; HUMANS; IMMUNOTOXINS; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; RIBOSOME INACTIVATING PROTEINS, TYPE 1; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84873179422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055304     Document Type: Article

References (21)

1. Daniotti JL, Iglesias-Bartolome R, (2011) Metabolic pathways and intracellular trafficking of gangliosides. IUBMB Life 63: 513-520.
2. Hakomori S, (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci U S A 99: 10231-10233.
3. Lee FT, Rigopoulos A, Hall C, Clarke K, Cody SH, et al. (2001) Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts. Cancer Res 61: 4474-4482.
4. Schengrund CL, Shochat SJ, (1988) Gangliosides in neuroblastomas. Neurochem Pathol 8: 189-202.
5. Allen TM, (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2: 750-763.
6. Thomas PB, Delatte SJ, Sutphin A, Frankel AE, Tagge EP, (2002) Effective targeted cytotoxicity of neuroblastoma cells. J Pediatr Surg 37: 539-544.
7. Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, et al. (1982) GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med 155: 1133-1147.
8. Iglesias-Bartolome R, Crespo PM, Gomez GA, Daniotti JL, (2006) The antibody to GD3 ganglioside, R24, is rapidly endocytosed and recycled to the plasma membrane via the endocytic recycling compartment. Inhibitory effect of brefeldin A and monensin. Febs J 273: 1744-1758.
9. Crespo PM, Zurita AR, Daniotti JL, (2002) Effect of gangliosides on the distribution of a glycosylphosphatidylinositol-anchored protein in plasma membrane from Chinese hamster ovary-K1 cells. J Biol Chem 277: 44731-44739.
10. Daniotti JL, Martina JA, Giraudo CG, Zurita AR, Maccioni HJ, (2000) GM3 alpha2,8-sialyltransferase (GD3 synthase): protein characterization and sub-golgi location in CHO-K1 cells. J Neurochem 74: 1711-1720.
11. Daniotti JL, Zurita AR, Trindade VM, Maccioni HJ, (2002) GD3 expression in CHO-K1 cells increases growth rate, induces morphological changes, and affects cell-substrate interactions. Neurochem Res 27: 1421-1429.
12. Daniotti JL, Rosales Fritz V, Kunda P, Nishi T, Maccioni HJ, (1997) Cloning, characterization and developmental expression of alpha2,8 sialyltransferase (GD3 synthase, ST8Sia I) gene in chick brain and retina. Int J Dev Neurosci 15: 767-776.
13. Gravotta D, Landa CA, Panzetta P, Maccioni HJ, (1989) In vivo and in vitro expression of gangliosides in chick retina Mueller cells. J Neurochem 52: 768-776.
14. Lo AS, Ma Q, Liu DL, Junghans RP, (2010) Anti-GD3 chimeric sFv-CD28/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors. Clin Cancer Res 16: 2769-2780.
15. Nasi ML, Meyers M, Livingston PO, Houghton AN, Chapman PB, (1997) Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside. Melanoma Res 7Suppl 2: S155-162.
16. Ravindranath MH, Morton DL, (1991) Role of gangliosides in active immunotherapy with melanoma vaccine. Int Rev Immunol 7: 303-329.
17. Stirpe F, Barbieri L, Battelli MG, Soria M, Lappi DA, (1992) Ribosome-inactivating proteins from plants: present status and future prospects. Biotechnology (N Y) 10: 405-412.
18. Alley SC, Okeley NM, Senter PD, (2010) Antibody-drug conjugates: targeted drug delivery for cancer. Curr Opin Chem Biol 14: 529-537.
19. Guillemard V, Saragovi HU, (2001) Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity. Cancer Res 61: 694-699.
20. Guillemard V, Uri Saragovi H, (2004) Prodrug chemotherapeutics bypass p-glycoprotein resistance and kill tumors in vivo with high efficacy and target-dependent selectivity. Oncogene 23: 3613-3621.
21. Polito L, Bolognesi A, Tazzari PL, Farini V, Lubelli C, et al. (2004) The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine. Leukemia 18: 1215-1222.